Water → HCID 68181596, compound
Reaction equation
C([SiH2][O:6][C:7](C)(C)[C:8]1([C:13]#[C:14][C:15]2[CH:16]=[CH:17][C:18]3[N:22]=[C:21]([CH3:23])[N:20]([C:24]4[N:29]=[CH:28][N:27]=[C:26]([NH2:30])[N:25]=4)[C:19]=3[CH:31]=2)[CH2:12][CH2:11][CH2:10][CH2:9]1)(C)(C)C.CCCC[N+](CCCC)(CCCC)CCCC.[F-].O>C1COCC1>[NH2:30][C:26]1[N:27]=[CH:28][N:29]=[C:24]([N:20]2[C:19]3[CH:31]=[C:15]([C:14]#[C:13][C:8]4([CH2:7][OH:6])[CH2:9][CH2:10][CH2:11][CH2:12]4)[CH:16]=[CH:17][C:18]=3[N:22]=[C:21]2[CH3:23])[N:25]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
4-{6-[1-(tert-butyl-dimethyl-silanyloxymethyl)-cyclopentylethynyl]-2-methyl-benzoimidazol-1-yl}-[1,3,5]triazin-2-ylamine (6-e) (80 mg, 0.17 mmol) was dissolved in THF (100 mL), TBAF (113 mg, 0.43 mmol) was added. The resulting mixture was stirred at room temperature for 12 h. Water (5 mL) was added, extracted with EtOAc. The organic phase was concentrated, purified via prep-TLC separation to afford the title target (27.5 mg, 47%): 1H NMR (400 MHz, DMSO) delta 1.55-1.76 (m, 8H), 2.86 (s, 3H), 3.40 (d, J=4.8 Hz, 2H), 4.96 (t, J=4.8 Hz, 1H), 7.25 (d, J=8.4 Hz, 1H), 7.50 (d, J=8.4 Hz, 1H), 7.90-8.10 (m, 2H), 8.30 (t, J=0.8 Hz, 1H), 8.63 (s, 1H). LCMS: m/z=+349.1 (M+H)+.
Workup
- extractionextracted with EtOAc
- concentrationThe organic phase was concentrated
- custompurified via prep-TLC separation
- customto afford the title target (27.5 mg, 47%)
Sources & evidence
- ORD record
- ord-afed54dc80f04f09a2b83db66614e942
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901313B2
Reaction notes
Loading…